{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["17"],"submitter":["Guirgis L"],"pubmed_abstract":["<h4>Background</h4>Pulmonary autograft reinforcement to prevent dilatation and subsequent neo-aortic valve regurgitation has been reported; however, data on long-term function of the neo-aortic valve after this modified Ross procedure are lacking. Our objective here was to assess long-term outcomes of the modified Ross procedure with autograft reinforcement using the reimplantation technique.<h4>Patients</h4>The outcomes of 61 consecutive patients managed using the Dacron-conduit reinforced Ross procedure between 2009 and 2021 were reviewed. Most patients had a unicuspid or bicuspid aortic valve (n = 52; 85%), predominant aortic valve regurgitation (n = 42; 77%), and >30 mm dilatation of the ascending aorta (n = 33; 54%). A prior aortic valve procedure was noted in 47 patients (77%) patien"],"journal":["JTCVS techniques"],"pagination":["121-128"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9938391"],"repository":["biostudies-literature"],"pubmed_title":["Outcomes after the Ross procedure with pulmonary autograft reinforcement by reimplantation."],"pmcid":["PMC9938391"],"pubmed_authors":["Guirgis L","Hascoet S","Belli E","Radojevic J","Cohen S","Van Aerschot I","Ly M"],"additional_accession":[]},"is_claimable":false,"name":"Outcomes after the Ross procedure with pulmonary autograft reinforcement by reimplantation.","description":"<h4>Background</h4>Pulmonary autograft reinforcement to prevent dilatation and subsequent neo-aortic valve regurgitation has been reported; however, data on long-term function of the neo-aortic valve after this modified Ross procedure are lacking. Our objective here was to assess long-term outcomes of the modified Ross procedure with autograft reinforcement using the reimplantation technique.<h4>Patients</h4>The outcomes of 61 consecutive patients managed using the Dacron-conduit reinforced Ross procedure between 2009 and 2021 were reviewed. Most patients had a unicuspid or bicuspid aortic valve (n = 52; 85%), predominant aortic valve regurgitation (n = 42; 77%), and >30 mm dilatation of the ascending aorta (n = 33; 54%). A prior aortic valve procedure was noted in 47 patients (77%) patien","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2025-04-04T13:35:46.942Z","creation":"2025-04-04T13:35:46.942Z"},"accession":"S-EPMC9938391","cross_references":{"pubmed":["36820346"],"doi":["10.1016/j.xjtc.2022.11.016"]}}